By: Benzinga
UPDATE: Jefferies Raises PT to $104 on ONYX Pharmaceuticals on Kyprolis Survey Data
Jefferies maintained ONYX Pharmaceuticals (NASDAQ: ONXX ) with a Buy rating and raised the price target from $96.00 to $104.00. Jefferies analyst Biren Amin commented, "Based on recent events incl frontline data and NCCN Compendium listing, and Pomalyst launch, we conducted a follow-up survey in myeloma, and observed 1st/2nd line
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here